Ventripoint Corporate Update

(firmenpresse) - SEATTLE, WASHINGTON -- (Marketwired) -- 10/20/15 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that James Bodtke, Vice-president, Clinical Affairs & Development for the Corporation has left the Company. Ventripoint wishes to thank Mr. Bodtke for his service and wishes him well in his future endeavors.

Additional information on Ventripoint is available on SEDAR at .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Ventripoint Diagnostics Ltd.
George Adams
President and CEO
(206) 910-9125

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 20.10.2015 - 13:27 Uhr
Sprache: Deutsch
News-ID 428160
Anzahl Zeichen: 0

contact information:
Town:

SEATTLE, WASHINGTON

Kategorie:

Medical Devices

Diese Pressemitteilung wurde bisher 261 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ventripoint Corporate Update"
steht unter der journalistisch-redaktionellen Verantwortung von

Ventripoint Diagnostics Ltd. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Ventripoint Provides Corporate Update ...

TORONTO, ONTARIO -- (Marketwired) -- 09/20/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSX VENTURE: VPT) is pleased to provide a corporate update on its marketing and development plans.The Company has re ...

Ventripoint Reports on Use of VMS Heart Analysis System to Reliably Measure Remo ...

TORONTO, ONTARIO -- (Marketwired) -- 08/21/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company") (TSX VENTURE: VPT) announces that the cardiology group at Royal Free Hospital in London, UK has published a study ent ...

Ventripoint Announces Results of Annual Shareholders' Meeting and Grant of ...

TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 the shareholders re-elected Dr ...

Alle Meldungen von Ventripoint Diagnostics Ltd.